GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,399 | -70.2% | 16,728 | -56.8% | 0.00% | – |
| Q2 2023 | $212,817 | +292.8% | 38,694 | +207.1% | 0.00% | – |
| Q1 2023 | $54,180 | +10.3% | 12,600 | +0.8% | 0.00% | – |
| Q4 2022 | $49,101 | -56.9% | 12,494 | -41.8% | 0.00% | – |
| Q3 2022 | $114,000 | -68.2% | 21,482 | -60.7% | 0.00% | – |
| Q2 2022 | $359,000 | +0.8% | 54,639 | +12.7% | 0.00% | – |
| Q1 2022 | $356,000 | +75.4% | 48,488 | +68.9% | 0.00% | – |
| Q4 2021 | $203,000 | -6.0% | 28,706 | +233.8% | 0.00% | – |
| Q3 2021 | $216,000 | -58.1% | 8,600 | -55.2% | 0.00% | – |
| Q2 2021 | $516,000 | -63.7% | 19,197 | -61.6% | 0.00% | – |
| Q1 2021 | $1,422,000 | +244.3% | 49,983 | +274.3% | 0.00% | – |
| Q3 2020 | $413,000 | -96.4% | 13,353 | -97.5% | 0.00% | -100.0% |
| Q2 2020 | $11,405,000 | – | 543,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |